To include your compound in the COVID-19 Resource Center, submit it here.

Glivec imatinib regulatory update

NVS said the Australian Pharmaceutical Benefits Advisory Committee (PBAC) had recommended for reimbursement

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE